Knowledge Hub

Childhood vaccination with PCVs reduces the incidence of invasive pneumococcal disease and benefits the whole population

A large study in Norway found that the overall incidence of invasive pneumococcal disease (IPD) declined significantly in individuals on immunosuppressive drugs following the introduction of PCVs for infants — and most significantly in people undergoing chemotherapy. These findings underscore the benefits that childhood vaccination with PCVs affords the entire population.

Full Citation:
Steens A, Winje BA, White RA et al.. 2019. Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: a case-cohort study. Clinical Infectious Diseases. 68(8).

Title of Article: Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: a case-cohort study

Author(s): Steens A, Winje BA, White RA et al.

Publication Year: 2019

Publication Name: Clinical Infectious Diseases

Publication Volume: 68(8)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/30957160

DOI (Digital Object Identifier): 10.1093/cid/ciy714

Topics: Health

Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia

Immunization Terms: Cancer

Countries: Norway

WHO Regions: Europe